Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report

Zoster meningitis in an immunocompetent young patient post first dose of BNT162b2 mRNA COVID-19 vaccine, a case report

Recently published observational data suggests an increased risk of herpes zoster infection post-vaccination with the BNT162b2 mRNA vaccine. We describe the case of VZV meningitis post BNT162b2 mRNA vaccination in a young immunocompetent patient. A 39-year-old patient with no medical history present...

Full description

Bibliographic Details
Main Authors: Colm Kerr, Susan O’Neill, Anna Szucs, Oliver Darmody, Claire Williamson, Ciaran Bannan, Concepta Merry
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:IDCases
Subjects:
COVID-19
MRNA
Vaccine
Zoster
Meningitis
Online Access:http://www.sciencedirect.com/science/article/pii/S2214250922000804

Internet

http://www.sciencedirect.com/science/article/pii/S2214250922000804

Similar Items